Tim Anderson
Stock Analyst at Wolfe Research
(2.84)
# 1,717
Out of 4,670 analysts
8
Total ratings
100%
Success rate
15.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tim Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Initiates: Peer Perform | n/a | $294.53 | - | 1 | Nov 15, 2024 | |
| ABBV AbbVie | Downgrades: Peer Perform | n/a | $176.95 | - | 3 | Feb 22, 2023 | |
| MRK Merck & Co. | Upgrades: Outperform | $127 | $99.18 | +28.05% | 2 | Feb 22, 2023 | |
| NVS Novartis AG | Downgrades: Peer Perform | n/a | $104.28 | - | 1 | May 9, 2022 | |
| AZN AstraZeneca | Upgrades: Outperform | n/a | $65.63 | - | 1 | Sep 22, 2017 |
Amgen
Nov 15, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $294.53
Upside: -
AbbVie
Feb 22, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $176.95
Upside: -
Merck & Co.
Feb 22, 2023
Upgrades: Outperform
Price Target: $127
Current: $99.18
Upside: +28.05%
Novartis AG
May 9, 2022
Downgrades: Peer Perform
Price Target: n/a
Current: $104.28
Upside: -
AstraZeneca
Sep 22, 2017
Upgrades: Outperform
Price Target: n/a
Current: $65.63
Upside: -